168 related articles for article (PubMed ID: 24338586)
1. Central retinal vein occlusion in a young patient following cannabis smoke inhalation.
Corvi F; Querques G; Lattanzio R; Preziosa C; Parodi MB; Bandello F
Eur J Ophthalmol; 2014; 24(3):437-40. PubMed ID: 24338586
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
Gu X; Yu X; Song S; Dai H
Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
7. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
8. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.
Singer M; Tan CS; Bell D; Sadda SR
Retina; 2014 Sep; 34(9):1736-42. PubMed ID: 24732695
[TBL] [Abstract][Full Text] [Related]
9. Combined central retinal vein occlusion and branch retinal artery occlusion treated with intravitreal dexamethasone implant: A case report.
Arrigo A; Knutsson KA; Rajabjan F; Augustin VA; Bandello F; Parodi MB
Eur J Ophthalmol; 2021 Mar; 31(2):NP74-NP76. PubMed ID: 32106703
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema.
Choi EY; Kang HG; Lee SC; Kim M
BMC Ophthalmol; 2019 Apr; 19(1):92. PubMed ID: 30999889
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
Manousaridis K; Peter S; Mennel S
Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
[TBL] [Abstract][Full Text] [Related]
12. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab and/or dexamethasone implant for macular edema secondary to retinal vein occlusion.
Nghiem-Buffet S; Fajnkuchen F; Buffet M; Ayrault S; Le Gloahec-Lorcy A; Grenet T; Delahaye-Mazza C; Quentel G; Cohen SY
Ophthalmologica; 2014; 232(4):216-22. PubMed ID: 25413000
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab for retinal vein occlusion through 1 year in clinical practice.
Brynskov T; Kemp H; Sørensen TL
Retina; 2014 Aug; 34(8):1637-43. PubMed ID: 24646663
[TBL] [Abstract][Full Text] [Related]
15. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial.
Brown DM; Wykoff CC; Wong TP; Mariani AF; Croft DE; Schuetzle KL;
Retina; 2014 Sep; 34(9):1728-35. PubMed ID: 24914476
[TBL] [Abstract][Full Text] [Related]
16. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.
Kreutzer TC; Wolf A; Dirisamer M; Strauss RW; Foerster P; Feltgen N; Pielen A; Hattenbach LO; Kampik A; Priglinger SG
Ophthalmologica; 2015; 233(1):8-17. PubMed ID: 25502833
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
[TBL] [Abstract][Full Text] [Related]
20. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
Eadie JA; Ip MS; Kulkarni AD
Retina; 2014 Dec; 34(12):2439-43. PubMed ID: 24999721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
